EnBio Holdings Balance Sheet Health
Financial Health criteria checks 4/6
EnBio Holdings has a total shareholder equity of ¥9.3B and total debt of ¥9.7B, which brings its debt-to-equity ratio to 103.8%. Its total assets and total liabilities are ¥21.0B and ¥11.7B respectively. EnBio Holdings's EBIT is ¥1.2B making its interest coverage ratio 18.4. It has cash and short-term investments of ¥3.4B.
Key information
103.8%
Debt to equity ratio
JP¥9.67b
Debt
| Interest coverage ratio | 18.4x |
| Cash | JP¥3.43b |
| Equity | JP¥9.32b |
| Total liabilities | JP¥11.67b |
| Total assets | JP¥20.99b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 6092's short term assets (¥8.8B) exceed its short term liabilities (¥5.1B).
Long Term Liabilities: 6092's short term assets (¥8.8B) exceed its long term liabilities (¥6.6B).
Debt to Equity History and Analysis
Debt Level: 6092's net debt to equity ratio (67%) is considered high.
Reducing Debt: 6092's debt to equity ratio has reduced from 163.2% to 103.8% over the past 5 years.
Debt Coverage: 6092's debt is not well covered by operating cash flow (4%).
Interest Coverage: 6092's interest payments on its debt are well covered by EBIT (18.4x coverage).